Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Invested Capital (2016 - 2018)

China Pharma Holdings' Return on Invested Capital history spans 8 years, with the latest figure at 0.08% for Q4 2018.

  • For Q4 2018, Return on Invested Capital rose 29.0% year-over-year to 0.08%; the TTM value through Dec 2018 reached 0.08%, up 29.0%, while the annual FY2018 figure was 0.07%, 29.0% up from the prior year.
  • Return on Invested Capital reached 0.08% in Q4 2018 per CPHI's latest filing, up from 0.41% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2017 to a low of 0.44% in Q1 2015.
  • Average Return on Invested Capital over 5 years is 0.21%, with a median of 0.17% recorded in 2016.
  • Peak YoY movement for Return on Invested Capital: rose 30bps in 2015, then tumbled -37bps in 2018.
  • A 5-year view of Return on Invested Capital shows it stood at 0.37% in 2014, then soared by 82bps to 0.07% in 2015, then skyrocketed by 45bps to 0.04% in 2016, then plummeted by -911bps to 0.37% in 2017, then skyrocketed by 79bps to 0.08% in 2018.
  • Per Business Quant, the three most recent readings for CPHI's Return on Invested Capital are 0.08% (Q4 2018), 0.41% (Q3 2018), and 0.38% (Q2 2018).